Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anticonvulsants | 5 | 2020 | 431 | 1.710 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2018 | 101 | 1.160 |
Why?
|
| Seizures | 7 | 2022 | 989 | 0.950 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2019 | 1546 | 0.770 |
Why?
|
| Chromones | 1 | 2019 | 120 | 0.710 |
Why?
|
| Mycophenolic Acid | 1 | 2018 | 148 | 0.630 |
Why?
|
| Morpholines | 1 | 2019 | 289 | 0.630 |
Why?
|
| Ginkgo biloba | 1 | 2017 | 16 | 0.600 |
Why?
|
| Pentylenetetrazole | 5 | 2020 | 29 | 0.590 |
Why?
|
| Carotenoids | 1 | 2016 | 96 | 0.550 |
Why?
|
| Plant Extracts | 1 | 2017 | 215 | 0.510 |
Why?
|
| Epilepsy | 4 | 2019 | 883 | 0.450 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 987 | 0.410 |
Why?
|
| Cognitive Dysfunction | 1 | 2016 | 333 | 0.410 |
Why?
|
| Sirolimus | 1 | 2016 | 814 | 0.400 |
Why?
|
| Zebrafish | 4 | 2020 | 463 | 0.360 |
Why?
|
| Kindling, Neurologic | 2 | 2020 | 12 | 0.340 |
Why?
|
| Brain | 2 | 2019 | 4113 | 0.330 |
Why?
|
| Rats, Wistar | 3 | 2019 | 562 | 0.320 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 521 | 0.300 |
Why?
|
| Maze Learning | 2 | 2017 | 132 | 0.290 |
Why?
|
| Behavior, Animal | 3 | 2019 | 709 | 0.280 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 7222 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2019 | 2054 | 0.230 |
Why?
|
| Motor Disorders | 1 | 2022 | 6 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2019 | 123 | 0.220 |
Why?
|
| Signal Transduction | 3 | 2019 | 11965 | 0.210 |
Why?
|
| Epilepsy, Absence | 1 | 2022 | 35 | 0.210 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 72 | 0.200 |
Why?
|
| Hippocampus | 2 | 2018 | 915 | 0.200 |
Why?
|
| Pilocarpine | 2 | 2019 | 21 | 0.200 |
Why?
|
| Disabled Persons | 1 | 2022 | 121 | 0.190 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 29 | 0.180 |
Why?
|
| Coumarins | 1 | 2019 | 33 | 0.180 |
Why?
|
| Animals | 10 | 2022 | 59536 | 0.170 |
Why?
|
| alpha-Linolenic Acid | 1 | 2019 | 17 | 0.170 |
Why?
|
| Convulsants | 1 | 2019 | 30 | 0.170 |
Why?
|
| Larva | 1 | 2019 | 274 | 0.160 |
Why?
|
| Lithium Chloride | 1 | 2017 | 28 | 0.150 |
Why?
|
| Ribosomal Protein S6 | 1 | 2017 | 46 | 0.150 |
Why?
|
| Crocus | 1 | 2016 | 1 | 0.150 |
Why?
|
| Plant Leaves | 1 | 2017 | 61 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 300 | 0.150 |
Why?
|
| Temporal Lobe | 1 | 2018 | 192 | 0.140 |
Why?
|
| Neurons | 2 | 2018 | 2287 | 0.140 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2017 | 131 | 0.140 |
Why?
|
| Phytotherapy | 1 | 2017 | 110 | 0.140 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 266 | 0.140 |
Why?
|
| Pyrroles | 1 | 2019 | 576 | 0.130 |
Why?
|
| Interleukin-2 | 1 | 2018 | 842 | 0.130 |
Why?
|
| Aggression | 1 | 2017 | 252 | 0.130 |
Why?
|
| Gene Expression | 2 | 2019 | 3570 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2019 | 732 | 0.110 |
Why?
|
| Myocardium | 1 | 2019 | 1313 | 0.110 |
Why?
|
| Comorbidity | 1 | 2018 | 2352 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 1678 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2016 | 786 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2019 | 6150 | 0.090 |
Why?
|
| Anxiety | 1 | 2017 | 1179 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2016 | 1549 | 0.090 |
Why?
|
| Rats | 1 | 2018 | 6086 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 4938 | 0.080 |
Why?
|
| Depression | 1 | 2017 | 1715 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 4320 | 0.070 |
Why?
|
| Male | 5 | 2019 | 123000 | 0.070 |
Why?
|
| Ataxia | 1 | 2022 | 176 | 0.050 |
Why?
|
| Mice | 2 | 2022 | 34495 | 0.050 |
Why?
|
| Swimming | 1 | 2019 | 27 | 0.040 |
Why?
|
| Lithium Compounds | 1 | 2019 | 15 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2019 | 144 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 79 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 163 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 503 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 703 | 0.040 |
Why?
|
| Fibrosis | 1 | 2019 | 793 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 558 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 2450 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 4053 | 0.020 |
Why?
|
| Humans | 3 | 2022 | 261506 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5159 | 0.020 |
Why?
|
| Female | 1 | 2019 | 141928 | 0.000 |
Why?
|